Target intelligence / Profile preview

Extracellular Matrix and Cell Surfaces at Implantation Site

Molecular classification
Extracellular matrix protein, Cell adhesion molecule, Proteoglycan, Glycoprotein
01

Overview

The Extracellular Matrix (ECM) and Cell Surfaces at the Implantation Site constitute the dynamic structural and biochemical environment of the uterine endometrium required for successful pregnancy (PMID: 11336305). This complex includes a variety of macromolecules such as laminins, fibronectins, and collagens, as well as cell-surface glycoproteins like MUC1 and various integrins, notably alpha-V beta-3 (PMID: 16123070). These components are essential for the three stages of implantation: apposition, adhesion, and invasion of the blastocyst into the maternal decidua (PMID: 12735220). Dysregulation of these matrix components or their associated receptors is a significant factor in reproductive disorders, including recurrent implantation failure, endometriosis, and preeclampsia (PMID: 25591464). While this site is not a single molecular target, specific elements such as hyaluronan and heparan sulfate proteoglycans are therapeutically modulated using agents like "embryo glue" or low-molecular-weight heparins to enhance adhesion and improve clinical pregnancy rates (PMID: 24435778). Understanding the molecular composition of this interface is crucial for developing targeted interventions for infertility and pregnancy-related complications.

Other names
Endometrial extracellular matrixImplantation window cell surfacesMaternal-fetal interface ECMDecidual extracellular matrix
02

Mechanism of action

Modulation of the adhesive properties and structural integrity of the endometrial-blastocyst interface to facilitate successful embryo attachment and invasion.

03

Biological functions

Cell adhesionEmbryo implantationTrophoblast invasionTissue remodelingSignal transduction
04

Disease associations

InfertilityRecurrent implantation failurePreeclampsiaEndometriosisRecurrent pregnancy loss
05

Safety considerations

Risk of placental abruptionPotential for abnormal trophoblast invasionSystemic effects on coagulationTeratogenicity
06

Interacting drugs

Heparin

3 more in the full profile.

07

Biomarkers

Integrin alpha-V beta-3MUC1L-selectin ligandGlycodelinOsteopontin

Beyond the preview

Go deeper on Extracellular Matrix and Cell Surfaces at Implantation Site.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular Matrix and Cell Surfaces at Implantation Site.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call